�������ýҕ�l

Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drugmakers increased their wholesale prices by 4.9% in the second quarter this year, up slightly from 4.4% a year earlier. But when accounting for inflation, wholesale prices fell by 3.7%, and inflationary pressures are likely to push wholesale prices still higher. (Silverman, 9/23)

Some key House Republicans are calling for the repeal of Democrats' newly-passed drug pricing measure if the GOP flips control of one or both chambers of Congress next year. (Sullivan and Knight, 9/23)

Senate and House health committee leaders on Thursday reached an agreement to renew programs that fund key Food and Drug Administration programs for another five years. (Knight and Sullivan, 9/22)

As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned. (Gutowski and St. Clair, 9/22)

Digital health care has its advantages. Privacy isn’t one of them. In a nation with millions of uninsured families and a shortage of health professionals, many of us turn to health-care apps and websites for accessible information or even potential treatment. But when you fire up a symptom-checker or digital therapy app, you might be unknowingly sharing your concerns with more than just the app maker. (Hunter and Merrill, 9/22)

Newly published details about a high-profile Apple Watch study call it “a priority” to recruit Medicaid patients — a population not usually considered the target for Apple’s pricey products. (Aguilar, 9/22)